W.E. Gillanders
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Cells and Metastasis
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
-
- Immunotherapy and Immune Responses 3
- T-cell and B-cell Immunology 2
- Immune Cell Function and Interaction 1
- Oncology 3
- Cancer Immunotherapy and Biomarkers 3
- Cancer Cells and Metastasis 2
- HER2/EGFR in Cancer Research 1
- Co-authors
- Savas D. Soysal (3 shared papers)Feng Gao (3 shared papers)Simone Muenst (3 shared papers)S. Peter Goedegebuure (1 shared paper)Daniel Oertli (2 shared papers)Ellen C. Obermann (1 shared paper)Emanuele Trella (1 shared paper)Paul Zajac (1 shared paper)
- Journals
- Breast Cancer Research and Treatment (2 papers)Annals of Oncology (1 paper)British Journal of Cancer (1 paper)Transplantation (1 paper)The Journal of Experimental Medicine (1 paper)
- Partner nations
- United StatesSwitzerlandAustria
In The Last Decade
W.E. Gillanders
6 papers receiving 1.1k citations
W.E. Gillanders's Hit Papers
Peers
Comparison fields: 5 of 60
- Oncology 729
- Immunology 414
- Cancer Research 97
- Psychiatry and Mental health 47
- Pulmonary and Respiratory Medicine 101
Countries citing papers authored by W.E. Gillanders
This map shows the geographic impact of W.E. Gillanders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.E. Gillanders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.E. Gillanders more than expected).
Fields of papers citing papers by W.E. Gillanders
This network shows the impact of papers produced by W.E. Gillanders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.E. Gillanders. The network helps show where W.E. Gillanders may publish in the future.
Co-authors
The 25 scholars most cited alongside W.E. Gillanders, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer Hit paper breakdown → | 2014 | 467 |
| 2 | 2013 | 283 | |
| 3 | 2017 | 186 | |
| 4 | 2013 | 105 | |
| 5 | 2023 | 19 | |
| 6 | 1997 | 4 |
About W.E. Gillanders
W.E. Gillanders is a scholar working on Immunology, Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Infectious Diseases, having authored 6 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), Immunotherapy and Immune Responses (3 papers), Cancer Cells and Metastasis (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), T-cell and B-cell Immunology (2 papers), Immune Cell Function and Interaction (1 paper), Chemical Synthesis and Analysis (1 paper) and HER2/EGFR in Cancer Research (1 paper). The work is most often cited by research in Oncology (729 citations), Immunology (414 citations), Cancer Research (97 citations), Psychiatry and Mental health (47 citations) and Pulmonary and Respiratory Medicine (101 citations). W.E. Gillanders has collaborated with scholars based in United States, Switzerland and Austria. Frequent co-authors include Savas D. Soysal, Feng Gao, Simone Muenst, S. Peter Goedegebuure, Daniel Oertli, Ellen C. Obermann, Emanuele Trella, Paul Zajac, Rosanna Zanetti and Manuele Giuseppe Muraro. Their work appears in journals such as Breast Cancer Research and Treatment, Annals of Oncology, British Journal of Cancer, Transplantation and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.